Integra LifeSciencesIART
那斯達克 · USD
16.07
-0.19
(-1.17%)
盤中 09/10 01:29 (UTC+8)
09/10 01:29 (UTC+8)
Integra LifeSciencesIART
16.07
-0.19
(-1.17%)
財務數據
損益表
- 3.69
- 4.18
- 3.81
- 4.43
- 3.83
- 4.16
- 4.02
- 4.35
- 3.92
- 4.19
- -7.09
- 13.37
- -8.93
- 16.23
- -13.55
- 8.61
- -3.26
- 8.17
- -9.89
- 6.85
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 418,761 | 391,918 | 434,925 | 402,062 | 415,605 | 382,653 | 442,646 | 380,834 | 418,175 | 368,872 |
營業成本 | 199,017 | 174,936 | 214,060 | 195,071 | 206,273 | 188,221 | 193,574 | 180,596 | 192,258 | 162,038 |
營業毛利 | 219,744 | 216,982 | 220,865 | 206,991 | 209,332 | 194,432 | 249,072 | 200,238 | 225,917 | 206,834 |
營業費用 | 200,459 | 205,512 | 197,825 | 195,230 | 722,006 | - | - | - | - | 202,870 |
研發費用 | 24,253 | 23,501 | 24,790 | 22,456 | 26,997 | 24,728 | 31,210 | 27,435 | 29,767 | 26,965 |
推銷及管理費用 | 172,436 | 178,235 | 169,267 | 169,046 | 179,890 | 181,497 | 178,520 | 177,193 | 195,472 | 165,798 |
非經常性項目費用 | - | - | - | - | 511,365 | - | - | - | - | - |
其他營業費用 | 3,770 | 3,776 | 3,768 | 3,728 | 3,754 | 3,704 | 3,715 | 3,761 | 3,707 | 10,107 |
營業利益 | 19,285 | 11,470 | 23,040 | 11,761 | -512,674 | -15,497 | 35,627 | -8,151 | -3,029 | 3,964 |
其他收入及費用 | 8,451 | 8,586 | 4,943 | 4,140 | 2,764 | 4,276 | 5,898 | 7,161 | 6,495 | 4,430 |
利息費用 | 22,994 | 22,465 | 23,673 | 22,725 | 21,042 | 18,815 | 18,984 | 19,373 | 18,651 | 13,624 |
稅前純益 | 4,742 | -2,409 | 4,310 | -6,824 | -530,952 | -30,036 | 22,541 | -20,363 | -15,185 | -5,230 |
所得稅 | 259 | 2,208 | 6,014 | -1,420 | -46,879 | -4,743 | 3,106 | -9,667 | -2,783 | -1,949 |
稅後純益 | 4,483 | -4,617 | -1,704 | -5,404 | -484,073 | -25,293 | 19,435 | -10,696 | -12,402 | -3,281 |
基本每股稅後盈餘(元) | 0.06 | -0.06 | -0.02 | -0.07 | -6.31 | -0.33 | 0.25 | -0.14 | -0.16 | -0.04 |
稀釋每股稅後盈餘(元) | 0.06 | -0.06 | -0.02 | -0.07 | -6.32 | -0.33 | 0.25 | -0.14 | -0.16 | -0.04 |
基本平均股數(千股) | 77779.00 | 76951.00 | 77887.00 | 76753.00 | 76695.00 | 77712.00 | 77164.00 | 77134.00 | 77583.00 | 78749.00 |
稀釋平均股數(千股) | 78168.00 | 76951.00 | 77887.00 | 76753.00 | 76695.00 | 77712.00 | 77164.00 | 77134.00 | 77583.00 | 78749.00 |
還原基本每股稅後盈餘(元) | 0.06 | -0.06 | -0.02 | -0.07 | -6.31 | -0.33 | 0.25 | -0.14 | -0.16 | -0.04 |
還原稀釋每股稅後盈餘(元) | 0.06 | -0.06 | -0.02 | -0.07 | -6.32 | -0.33 | 0.25 | -0.14 | -0.16 | -0.04 |
還原基本平均股數(千股) | 77,779 | 76,951 | 77,887 | 76,753 | 76,695 | 77,712 | 77,164 | 77,134 | 77,583 | 78,749 |
還原稀釋平均股數(千股) | 78,168 | 76,951 | 77,887 | 76,753 | 76,695 | 77,712 | 77,164 | 77,134 | 77,583 | 78,749 |
EBITDA(千元) | 66,891 | 59,481 | 67,428 | 55,738 | -470,328 | 27,352 | 80,514 | 36,306 | 41,703 | 40,358 |